The sophistication of modern cancer treatments lies in their ability to target specific cellular pathways, minimizing damage to healthy tissues. At the heart of many such targeted therapies are complex organic molecules, often built from specialized chemical intermediates. One such critical intermediate is the Pyrido[2,3-d]pyrimidin-7(8H)-one derivative, identified by CAS number 571190-30-2. This compound, chemically known as 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-Pyrido[2,3-d]pyrimidin-7(8H)-one, serves as a fundamental building block for advanced pharmaceutical research, particularly in the development of CDK4/6 inhibitors.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing the pharmaceutical industry with high-quality chemical components that drive innovation. Our Pyrido[2,3-d]pyrimidin-7(8H)-one derivative is supplied as a pristine white powder, boasting a purity of ≥99%. This high level of purity is non-negotiable in pharmaceutical synthesis, ensuring that the resulting APIs, such as Palbociclib, are synthesized efficiently and effectively. The chemical structure of this intermediate provides a robust scaffold that is essential for the biological activity of the final drug product.

For researchers and chemists, understanding the precise role of each intermediate is crucial. Searching for terms like 'Pyrido[2,3-d]pyrimidin-7(8H)-one derivatives structure' or 'chemical backbone of targeted therapies' highlights the need for detailed chemical information and reliable sourcing. Our company ensures that this information is readily available, alongside the assurance of consistent quality and supply. The availability of this intermediate from various manufacturers and suppliers contributes to a healthy competitive market, ultimately benefiting research and development efforts worldwide.

The applications of CAS 571190-30-2 are broad within the pharmaceutical research context. Beyond its role as a synthetic intermediate, it is also valuable as a reference standard. This allows for rigorous quality control processes, ensuring that the synthesis and purification steps for related compounds are accurately monitored. By providing this essential compound, NINGBO INNO PHARMCHEM CO.,LTD. supports the entire lifecycle of drug development, from early-stage research to commercial production. The ongoing advancements in oncology demand a steady and reliable supply of such foundational chemicals.

In conclusion, the Pyrido[2,3-d]pyrimidin-7(8H)-one derivative represents a key element in the chemical architecture of cutting-edge cancer therapies. NINGBO INNO PHARMCHEM CO.,LTD. is proud to be a reliable supplier, empowering scientific progress in the critical field of oncology.